Tandem Diabetes Care

Yahoo Finance • 6 days ago

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting fr... Full story

Yahoo Finance • 10 days ago

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Allstate, Chubb Ltd., Eli Lilly, KLA Corp., Lockheed Martin, MongoDB, Roku, and More

Thinkstock Quick Read The rotation trade had another run on Wall Street Monday, as tech stocks led the selling once again. While the move away from the AI/Data center trade has gained some strength, the reality is that with a likely thir... Full story

Yahoo Finance • 14 days ago

Don't Buy Tandem Diabetes Care Until This Big Thing Happens

Key Points Tandem Diabetes Care's top-line growth hasn't been great over the past few years. If it can successfully address challenges detrimental to revenue growth, it may become an attractive stock -- even with red ink on the bottom lin... Full story

Yahoo Finance • last month

Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a fur... Full story

Yahoo Finance • 2 months ago

Tandem Diabetes Care outlines path to $1B sales milestone and gross margin gains in 2025 while expanding pharmacy channel

Earnings Call Insights: Tandem Diabetes Care (TNDM) Q3 2025 MANAGEMENT VIEW * John Sheridan, President and CEO, highlighted "significant strategic milestones and delivered record Q3 sales" and stated, "Our substantial progress is start... Full story

Yahoo Finance • 2 months ago

Tandem Diabetes Care soars after double Q3 beats

[Third Quarter Q3 Profits Stock Trading Chart 3D Background] filo * Tandem Diabetes Care is up ~16% in after-hours trading Thursday after posting beats [https://seekingalpha.com/news/4517898-tandem-diabetes-care-gaap-eps-of-0_31-beats-b... Full story

Yahoo Finance • 2 months ago

t:slim X2™ Insulin Pump Now Available with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States

The t:slim X2™ Insulin Pump with Abbott’s FreeStyle Libre® 3 Plus Sensor is now available in the United States, beginning global commercial rollout. Tandem Diabetes Care begins global commercial rollout of t:slim X2 pump integration with... Full story

Yahoo Finance • 2 months ago

United States Insulin Pump Market Outlook and Company Analysis Report 2025-2033 Featuring Medtronic, Insulet, Tandem Diabetes Care, Roche, Ypsomed, Microtech Medical

Company Logo The United States Insulin Pump Market is projected to grow from US$ 1.55 billion in 2024 to US$ 2.58 billion in 2033, with a CAGR of 5.84% from 2025-2033. This growth is driven by the rising diabetes prevalence, technological... Full story

Yahoo Finance • 3 months ago

Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the suggestion of canceling... Full story

Yahoo Finance • 3 months ago

agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. The pharmaceutical and b... Full story

Yahoo Finance • 3 months ago

Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

LOS ANGELES, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) in... Full story

Yahoo Finance • 3 months ago

Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) on behalf of investors concerning the Company’s possibl... Full story

Yahoo Finance • 3 months ago

Tandem t:slim X2 Insulin Pump Now Compatible With Lyumjev Ultra-Rapid Acting Insulin in the United States

SAN DIEGO, September 29, 2025--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ automated insulin deli... Full story

Yahoo Finance • 4 months ago

Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Price Index (CPI) report,... Full story

Yahoo Finance • 4 months ago

Tandem Diabetes upgraded at Citi on risk-reward setup

[Wall Street New York stock exchange stock market] alexsl Tandem Diabetes Care (NASDAQ:TNDM [https://seekingalpha.com/symbol/TNDM]) traded higher on Tuesday after Citi upgraded the insulin pump maker to Neutral from Sell, citing a shift i... Full story

Yahoo Finance • 4 months ago

Tandem Diabetes Care Inc. (TNDM) - Product Pipeline Analysis Report 2025

Dublin, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The "Tandem Diabetes Care Inc (TNDM) - Product Pipeline Analysis, 2025 Update" has been added to ResearchAndMarkets.com's offering. Tandem Diabetes Care Inc, a leading provider in the realm of... Full story

Yahoo Finance • 5 months ago

Piper Sandler downgrades Tandem Diabetes stock on weak domestic outlook

Investing.com - Piper Sandler downgraded Tandem Diabetes Care (NASDAQ:TNDM) from Overweight to Neutral on Thursday, while significantly reducing its price target to $14.00 from $30.00. The stock, currently trading at $14.39, has fallen ove... Full story

Yahoo Finance • 5 months ago

Tandem Diabetes Care Inc (NASDAQ:TNDM) Reports Mixed Q2 2025 Results with Revenue Miss and Wider Loss

Tandem Diabetes Care Inc (NASDAQ:TNDM [https://www.chartmill.com/stock/quote/TNDM]) reported mixed second-quarter 2025 results, with revenue slightly below analyst expectations and a wider-than-anticipated loss per share. The company also... Full story

Yahoo Finance • 5 months ago

Tandem Diabetes Care stock hits 52-week low at 14.86 USD

Tandem Diabetes Care (NASDAQ:TNDM) Inc’s stock has reached a new 52-week low, trading at 14.86 USD, down significantly from its 52-week high of 47.60 USD. This milestone comes amidst a challenging year for the company, with InvestingPro da... Full story

Yahoo Finance • 5 months ago

Abbott Labs stock rating reiterated by Piper Sandler ahead of Q2 earnings

Investing.com - Piper Sandler has reiterated an Overweight rating and $150.00 price target on Abbott Labs (NYSE:ABT), currently trading near its 52-week high at $131.60, ahead of the company’s second-quarter earnings report expected on Jul... Full story